 | Dermavir (GIC)ICO Dermavir is a Dendritic Cell-Targeting Therapeutic Vaccine Technology Platform. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenWhat is Dermavir
Therapeutic Vaccine for treatment of HIV, referred to as DermaVir, is effective in boosting immune response which kills HIV-infected cells. Human clinical trials have demonstrated vaccine is capable of killing HIV-infected cells. DermaVir has a safety profile similar to vaccines used in healthy adults and children. DermaVir can also be a co-treatment option if administered with antiretroviral therapy.
DetailsPre-sales: Mar 30, 2018 - May 15, 2018Public sales: May 15, 2018 - May 30, 2018 Pre-sale token supply: 9000000 Token supply: 1000000 LegalRegistration country: HungaryRegistration year: 1988 Office address: Berlini ut 47-49 Budapest, 1043 Hungary BountyBounty: 3% | Token infoTicker: GICType: Utility-token Token standard: ERC-20 Token price in USD: 1 Token = 1.000000 USD Accepted currencies: ETH Bonus program: Presale 1st stage - 30% discount Presale 2nd stage - 20% discount Presale 3rd stage - 10% discount Token distribution: 66% - ICO 3% - Bounty 21% - future sell Funds allocation: 15% - FDA Documentation 19% - Vaccines Design Team 19% - Salaries 4% - Experts fees 4% - Consultation fees 6% - Company Operations 4% - Legal 12% - Research 2% - Equipment 3% - Travel 6% - Patenting 6% - Reserve |
Social media
